Clinical and cytogenetic results of a series of amniocentesis cases from Northeast China: A report of 2500 cases

Genetics and Molecular Research

Volumn 14, Issue 4, 2015, Pages 15660-15667

  An, N ^a   Li, L L ^a   Wang, R X ^a   Yue, J M ^a   Liu, R Z ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Amniocentesis; Chromosomal abnormality; Genetic counselling; Prenatal diagnosis

Indexed keywords

AMNIOCENTESIS; AMNION FLUID ANALYSIS; ARTICLE; CHINA; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; DISEASE ASSOCIATION; FEMALE; FETUS; HUMAN; INCIDENCE; MATERNAL AGE; MATERNAL BLOOD; PRENATAL DIAGNOSIS; SCREENING TEST; ADULT; CHROMOSOME DISORDERS; GENETICS; MALE; PREGNANCY; PREGNANCY OUTCOME; PROCEDURES; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY;

ABNORMAL KARYOTYPE; ADULT; AMNIOCENTESIS; CHINA; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CYTOGENETICS; FEMALE; HUMANS; INCIDENCE; MALE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES;

EID: 84979765681     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.December.1.18     Document Type: Article

References (18)

1. Alfirevic Z, Sundberg K and Brigham S (2003). Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. CD003252.
2. Benn P, Borell A, Chiu R, Cuckle H, et al. (2013). Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat. Diagn. 33: 622-629.
3. Caron L, Tihy F and Dallaire L (1999). Frequencies of chromosomal abnormalities at amniocentesis: over 20 years of cytogenetic analyses in one laboratory. Am. J. Med. Genet. 82: 149-154.
4. Cerrillo Hinojosa M, Yerena de Vega MC, Gonzalez Panzzi ME, Godoy H, et al. (2009). Genetic amniocentesis in high-risk populations. Experience in 3081 cases. Ginecol. Obstet. Mex. 77: 173-182.
5. Crandall BF and Sparkes RS (1973). Prenatal diagnosis of genetic disorders by amniocentesis. Calif. Med. 119: 1-6.
6. Daniilidis A, Karydas H, Zournatzi V, Tantanasis T, et al. (2008). A four-year retrospective study of amniocentesis: one centre experience. Hippokratia 12: 113-115.
7. Forabosco A, Percesepe A and Santucci S (2009). Incidence of non-age-dependent chromosomal abnormalities: a population-based study on 88965 amniocenteses. Eur. J. Hum. Genet. 17: 897-903.
8. Han SH, An JW, Jeong GY, Yoon HR, et al. (2008). Clinical and cytogenetic finding on 31,615 mid-trimester amniocenteses. Korean J. Lab. Med. 28: 378-385.
9. Karaoguz MY, Bal F, Yakut T, Ercelen NO, et al. (2006). Cytogenetic results of amniocentesis materials: incidence of abnormal karyotypes in the Turkish collaborative study. Genet. Couns. 17: 219-230.
10. Kim YJ, Lee JE, Kim SH, Shim SS, et al. (2013). Maternal age-specific rates of fetal chromosomal abnormalities in Korean pregnant women of advanced maternal age. Obstet. Gynecol. Sci. 56: 160-166.
11. Nakata N, Wang Y and Bhatt S (2010). Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age. Prenat Diagn. 30: 198-206.
12. Neagos D, Cretu R, Sfetea RC and Bohiltea LC (2011). The importance of screening and prenatal diagnosis in the identification of the numerical chromosomal abnormalities. Maedica 6: 179-184.
13. Ocak Z, Özlü T, Yazıcıoglu HF, Özyurt O, et al. (2014). Clinical and cytogenetic results of a large series of amniocentesis cases from Turkey: report of 6124 cases. J. Obstet. Gynaecol. Res. 40: 139-146.
14. Qi QW, Jiang YL, Zhou XY, Liu JT, et al. (2013). Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study. Chin. Med. J. 126: 2007-2010.
15. Shaw-Smith C, Rendon R, Rickman L, Rio M, et al. (2004). Microarray based comparative genomic hybridisation (array- CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J. Med. Genet. 41: 241-248.
16. Simpson NE, Dallaire L, Miller JR, Siminovich L, et al. (1976). Prenatal diagnosis of genetic disease in Canada: report of a collaborative study. Can. Med. Assoc. J. 23: 739-748.
17. Tseng JJ, Chou MM, Lo FC, Lai HY, et al. (2006). Detection of chromosome aberrations in the second trimester using genetic amniocentesis: experience during 1995-2004. Taiwan J. Obstet. Gynecol. 45: 39-41.
18. Warburton D (1991). De novo balanced chromosome rearrangements and extra marker chromosomes identified at prenatal diagnosis: clinical significance and distribution of breakpoints. Am. J. Hum. Genet. 49: 995-1013.